StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AcquisitionsMay 29, 2026, 04:09 PM

Genenta Science Acquires Remaining 80.5% Equity in A.T.C. for €9.6M

AI Summary

Genenta Science S.p.A. completed the acquisition of the remaining 80.5% equity ownership in A.T.C. S.r.l. for an aggregate purchase price of Euro 9,604,076.82. The payment was made by setting off the amount owed by A.T.C. Shareholders for subscribing to 24,625,838 ordinary shares of Genenta Science at Euro 0.39 per share. The acquired shares are subject to a 36-month lock-up period, and the agreement includes both put and call options for the shares.

Key Highlights

  • Genenta Science acquired the remaining 80.5% equity ownership in A.T.C. S.r.l.
  • The aggregate purchase price for the acquisition was Euro 9,604,076.82.
  • Payment was made by setting off the amount owed by A.T.C. Shareholders for subscribing to 24,625,838 ordinary shares of Genenta Science.
  • The subscription price per share for Genenta Science's ordinary shares was Euro 0.39.
  • The ordinary shares allotted to A.T.C. Shareholders are subject to a 36-month lock-up period.
  • A.T.C. Shareholders were granted a put option exercisable from the third to fifth anniversary of issuance.
  • Genenta Science was granted a call option exercisable from the first to third anniversary of issuance.